Physician
Amponsah, Kwame
Amponsah, Kwame was paid $54K by Medicaid between Jul 2018 and Feb 2020, across 22 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 35% of everything it billed.
33Billing provider infoAMPONSAH, KWAME
WORCESTER, MA 01604
WORCESTER, MA 01604
33aNPI1831416874assigned 04/30/2010
33bProvider typeObstetrics & Gynecology Physician
28Total paid$54K
24GClaims1,332
24DCodes billed22
24AFirst – last monthJul 2018 – Feb 2020
Compared with peers
Next to other Obstetrics & Gynecology Physician providers in Massachusetts
Rank by total paid#43 of 216
Median peer was paid$7K
This provider vs. median8.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 26 | $3K | |
| 2019 | 1,195 | $44K | |
| 2020 | 111 | $7K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 35% | 257 | 249 | $19K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 14% | 71 | 71 | $7K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 13% | 224 | 224 | $7K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 13% | 216 | 216 | $7K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 7.5% | 131 | 131 | $4K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 5.4% | 96 | 96 | $3K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 2.2% | 13 | 13 | $1K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 2.1% | 12 | 12 | $1K |
| 87481 | 1.6% | 12 | 12 | $870.12 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 1.3% | 26 | 26 | $682.98 |
| 99401 | <1% | 13 | 13 | $426.92 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 13 | 12 | $305.76 |
10 more codes
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 12 | $282.24 |
| 85027 | <1% | 34 | $276.38 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 26 | $246.71 |
| 81025 | <1% | 31 | $231.52 | |
| 86780 | <1% | 13 | $197.95 | |
| 87220 | <1% | 33 | $165.66 | |
| 87340 | <1% | 13 | $154.58 | |
| 83986 | <1% | 35 | $146.95 | |
| 82120 | <1% | 33 | $146.35 | |
| 87210 | <1% | 18 | $90.42 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.